Close Menu

NEW YORK (GenomeWeb) – Bio-Techne announced this week that it has agreed to acquire all of the stock of B-MoGen Biotechnologies. The transaction has been completed and is being financed through available cash on hand.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Hastings Center's Erik Parens argues in a Scientific American opinion piece that the current pandemic underscores the need to reconsider the hope placed in genomic medicine. 

The Sydney Morning Herald reports that Australia is launching its trial of preconception carrier testing Tuesday.

The Los Angeles Times writes that Operation Warp Speed has an ambitious timeline for developing a COVID-19 vaccine.

In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.